GSA Capital Partners’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Buy |
5,532
+4,862
| +726% | +$2.08M | 0.13% | 152 |
|
|
2025
Q4 | $287K | Buy |
670
+61
| +10% | +$26.6K | 0.02% | 1187 |
|
|
2025
Q3 | $273K | Buy |
+609
| New | +$276K | 0.02% | 1253 |
|
|
2025
Q2 | – | Sell |
-425
| Closed | -$262K | – | 1776 |
|
|
2025
Q1 | $262K | Buy |
+425
| New | +$242K | 0.02% | 1242 |
|
|
2024
Q3 | – | Sell |
-572
| Closed | -$310K | – | 1635 |
|
|
2024
Q2 | $310K | Buy |
+572
| New | +$328K | 0.02% | 1259 |
|
|
2023
Q4 | – | Sell |
-3,252
| Closed | -$1.69M | – | 1534 |
|
|
2023
Q3 | $1.69M | Sell |
3,252
-121
| -4% | -$62.9K | 0.14% | 160 |
|
|
2023
Q2 | $1.83M | Buy |
3,373
+1,669
| +98% | +$912K | 0.18% | 77 |
|
|
2023
Q1 | $916K | Buy |
+1,704
| New | +$869K | 0.09% | 361 |
|
|
2022
Q3 | – | Sell |
-553
| Closed | -$260K | – | 1553 |
|
|
2022
Q2 | $260K | Buy |
+553
| New | +$270K | 0.04% | 916 |
|
|
2021
Q2 | – | Sell |
-696
| Closed | -$320K | – | 1340 |
|
|
2021
Q1 | $320K | Sell |
696
-58
| -8% | -$28.4K | 0.05% | 602 |
|
|
2020
Q4 | $402K | Sell |
754
-1,694
| -69% | -$832K | 0.07% | 568 |
|
|
2020
Q3 | $1.18M | Buy |
+2,448
| New | +$1.2M | 0.2% | 70 |
|
|
2020
Q1 | – | Sell |
-1,064
| Closed | -$467K | – | 1107 |
|
|
2019
Q4 | $467K | Buy |
+1,064
| New | +$448K | 0.05% | 699 |
|
|
2019
Q3 | – | Sell |
-987
| Closed | -$356K | – | 1426 |
|
|
2019
Q2 | $356K | Sell |
987
-774
| -44% | -$259K | 0.04% | 887 |
|
|
2019
Q1 | $564K | Buy |
1,761
+747
| +74% | +$229K | 0.06% | 621 |
|
|
2018
Q4 | $287K | Sell |
1,014
-6,070
| -86% | -$1.83M | 0.03% | 861 |
|
|
2018
Q3 | $2.26M | Sell |
7,084
-190
| -3% | -$60.5K | 0.13% | 191 |
|
|
2018
Q2 | $2.34M | Buy |
7,274
+5,263
| +262% | +$1.65M | 0.12% | 202 |
|
|
2018
Q1 | $549K | Sell |
2,011
-1,079
| -35% | -$286K | 0.03% | 1014 |
|
|
2017
Q4 | $751K | Sell |
3,090
-2,675
| -46% | -$608K | 0.05% | 737 |
|
|
2017
Q3 | $1.17M | Buy |
5,765
+2,487
| +76% | +$489K | 0.08% | 420 |
|
|
2017
Q2 | $670K | Buy |
+3,278
| New | +$653K | 0.04% | 819 |
|
|
2016
Q4 | – | Sell |
-2,867
| Closed | -$404K | – | 1767 |
|
|
2016
Q3 | $404K | Buy |
+2,867
| New | +$399K | 0.02% | 1181 |
|
|
2016
Q2 | – | Sell |
-7,240
| Closed | -$981K | – | 1749 |
|
|
2016
Q1 | $981K | Buy |
7,240
+532
| +8% | +$71.9K | 0.06% | 551 |
|
|
2015
Q4 | $1M | Sell |
6,708
-6,692
| -50% | -$989K | 0.05% | 704 |
|
|
2015
Q3 | $1.79M | Buy |
13,400
+3,600
| +37% | +$504K | 0.09% | 323 |
|
|
2015
Q2 | $1.28M | Sell |
9,800
-759
| -7% | -$93.9K | 0.05% | 697 |
|
|
2015
Q1 | $1.26M | Buy |
10,559
+893
| +9% | +$99.1K | 0.05% | 678 |
|
|
2014
Q4 | $1.02M | Buy |
9,666
+3,419
| +55% | +$361K | 0.07% | 453 |
|
|
2014
Q3 | $643K | Buy |
+6,247
| New | +$633K | 0.03% | 767 |
|
|
2014
Q2 | – | Sell |
-3,001
| Closed | -$268K | – | 1817 |
|
|
2014
Q1 | $268K | Sell |
3,001
-1,800
| -37% | -$147K | 0.02% | 1214 |
|
|
2013
Q4 | $368K | Sell |
4,801
-636
| -12% | -$46.9K | 0.03% | 1069 |
|
|
2013
Q3 | $389K | Buy |
+5,437
| New | +$387K | 0.03% | 962 |
|
Other funds holding CHE
VPM
VCM
GSA Capital Partners's CHE Position: Q1 2026 in Review
GSA Capital Partners increased its Chemed (CHE) stake by 726% in Q1 2026, buying an estimated $2.08M and bringing the position to 5,532 shares worth $2.09M. The position accounts for 0.13% of the portfolio, ranked #152.
GSA Capital Partners first reported a position in CHE in Q3 2013 and has held it in 33 quarters since. The position peaked at $2.34M in Q2 2018. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.
- GSA Capital Partners held 5,532 shares of Chemed worth $2.09M as of Q1 2026.
- GSA Capital Partners bought 4,862 Chemed shares in Q1 2026, an estimated $2.08M.
- Chemed made up 0.13% of GSA Capital Partners's portfolio in Q1 2026, its #152 holding.
- GSA Capital Partners first reported a position in Chemed in Q3 2013 and has held it in 33 quarters since.
- GSA Capital Partners's Chemed position peaked at $2.34M in Q2 2018.
- 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.